Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 12 |
GO:0030896 | checkpoint clamp complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
Related structures:
AlphaFold database: Q4QD01
Term | Name | Level | Count |
---|---|---|---|
GO:0000075 | cell cycle checkpoint signaling | 4 | 12 |
GO:0000077 | DNA damage checkpoint signaling | 5 | 12 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006259 | DNA metabolic process | 4 | 12 |
GO:0006281 | DNA repair | 5 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0006950 | response to stress | 2 | 12 |
GO:0006974 | DNA damage response | 4 | 12 |
GO:0007165 | signal transduction | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0010564 | regulation of cell cycle process | 5 | 12 |
GO:0010948 | negative regulation of cell cycle process | 6 | 12 |
GO:0031570 | DNA integrity checkpoint signaling | 5 | 12 |
GO:0033554 | cellular response to stress | 3 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0035556 | intracellular signal transduction | 3 | 12 |
GO:0042770 | signal transduction in response to DNA damage | 4 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0045786 | negative regulation of cell cycle | 5 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0048519 | negative regulation of biological process | 3 | 12 |
GO:0048523 | negative regulation of cellular process | 4 | 12 |
GO:0050789 | regulation of biological process | 2 | 12 |
GO:0050794 | regulation of cellular process | 3 | 12 |
GO:0050896 | response to stimulus | 1 | 12 |
GO:0051716 | cellular response to stimulus | 2 | 12 |
GO:0051726 | regulation of cell cycle | 4 | 12 |
GO:0065007 | biological regulation | 1 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 12 |
GO:1901988 | negative regulation of cell cycle phase transition | 7 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004527 | exonuclease activity | 5 | 1 |
GO:0004529 | DNA exonuclease activity | 5 | 1 |
GO:0004536 | DNA nuclease activity | 4 | 1 |
GO:0008853 | obsolete exodeoxyribonuclease III activity | 7 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 279 | 283 | PF00656 | 0.727 |
CLV_C14_Caspase3-7 | 75 | 79 | PF00656 | 0.410 |
CLV_MEL_PAP_1 | 157 | 163 | PF00089 | 0.493 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.437 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.502 |
DEG_APCC_DBOX_1 | 152 | 160 | PF00400 | 0.594 |
DOC_CYCLIN_RxL_1 | 53 | 61 | PF00134 | 0.486 |
DOC_MAPK_gen_1 | 150 | 159 | PF00069 | 0.467 |
DOC_MAPK_HePTP_8 | 192 | 204 | PF00069 | 0.554 |
DOC_MAPK_MEF2A_6 | 153 | 161 | PF00069 | 0.482 |
DOC_MAPK_MEF2A_6 | 195 | 204 | PF00069 | 0.560 |
DOC_MAPK_MEF2A_6 | 340 | 348 | PF00069 | 0.506 |
DOC_MAPK_MEF2A_6 | 6 | 14 | PF00069 | 0.414 |
DOC_PP2B_LxvP_1 | 71 | 74 | PF13499 | 0.470 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.523 |
DOC_USP7_MATH_1 | 302 | 306 | PF00917 | 0.733 |
DOC_USP7_MATH_1 | 354 | 358 | PF00917 | 0.574 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.612 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.545 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.506 |
LIG_14-3-3_CanoR_1 | 141 | 147 | PF00244 | 0.558 |
LIG_14-3-3_CanoR_1 | 15 | 21 | PF00244 | 0.473 |
LIG_14-3-3_CanoR_1 | 160 | 166 | PF00244 | 0.337 |
LIG_14-3-3_CanoR_1 | 237 | 245 | PF00244 | 0.488 |
LIG_14-3-3_CanoR_1 | 322 | 326 | PF00244 | 0.496 |
LIG_14-3-3_CanoR_1 | 331 | 336 | PF00244 | 0.436 |
LIG_Actin_WH2_2 | 145 | 162 | PF00022 | 0.556 |
LIG_APCC_ABBA_1 | 37 | 42 | PF00400 | 0.423 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.388 |
LIG_deltaCOP1_diTrp_1 | 25 | 32 | PF00928 | 0.385 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.544 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.441 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.456 |
LIG_FHA_1 | 238 | 244 | PF00498 | 0.437 |
LIG_FHA_1 | 322 | 328 | PF00498 | 0.457 |
LIG_FHA_1 | 347 | 353 | PF00498 | 0.409 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.462 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.484 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.498 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.715 |
LIG_FHA_2 | 174 | 180 | PF00498 | 0.486 |
LIG_FHA_2 | 336 | 342 | PF00498 | 0.516 |
LIG_FHA_2 | 73 | 79 | PF00498 | 0.426 |
LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.410 |
LIG_LIR_Gen_1 | 25 | 32 | PF02991 | 0.400 |
LIG_LIR_Gen_1 | 289 | 297 | PF02991 | 0.668 |
LIG_LIR_Gen_1 | 61 | 70 | PF02991 | 0.516 |
LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 25 | 30 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 315 | 320 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 61 | 65 | PF02991 | 0.475 |
LIG_NRBOX | 142 | 148 | PF00104 | 0.550 |
LIG_PDZ_Class_3 | 357 | 362 | PF00595 | 0.618 |
LIG_PTB_Apo_2 | 284 | 291 | PF02174 | 0.684 |
LIG_PTB_Phospho_1 | 284 | 290 | PF10480 | 0.687 |
LIG_SH2_CRK | 4 | 8 | PF00017 | 0.412 |
LIG_SH2_NCK_1 | 62 | 66 | PF00017 | 0.527 |
LIG_SH2_STAP1 | 239 | 243 | PF00017 | 0.533 |
LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 290 | 293 | PF00017 | 0.673 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.389 |
LIG_SH3_3 | 348 | 354 | PF00018 | 0.434 |
LIG_SUMO_SIM_anti_2 | 349 | 354 | PF11976 | 0.473 |
LIG_SUMO_SIM_par_1 | 105 | 110 | PF11976 | 0.398 |
LIG_SUMO_SIM_par_1 | 18 | 23 | PF11976 | 0.429 |
LIG_SUMO_SIM_par_1 | 221 | 229 | PF11976 | 0.573 |
MOD_CDK_SPxxK_3 | 107 | 114 | PF00069 | 0.600 |
MOD_CK1_1 | 233 | 239 | PF00069 | 0.524 |
MOD_CK1_1 | 258 | 264 | PF00069 | 0.768 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.557 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.736 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.420 |
MOD_GlcNHglycan | 231 | 235 | PF01048 | 0.532 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.691 |
MOD_GlcNHglycan | 297 | 300 | PF01048 | 0.660 |
MOD_GlcNHglycan | 304 | 307 | PF01048 | 0.609 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.472 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.432 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.318 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.479 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.512 |
MOD_GSK3_1 | 255 | 262 | PF00069 | 0.761 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.332 |
MOD_GSK3_1 | 331 | 338 | PF00069 | 0.433 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.420 |
MOD_N-GLC_1 | 46 | 51 | PF02516 | 0.537 |
MOD_NEK2_1 | 142 | 147 | PF00069 | 0.466 |
MOD_NEK2_1 | 273 | 278 | PF00069 | 0.762 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.620 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.455 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.455 |
MOD_NEK2_2 | 312 | 317 | PF00069 | 0.643 |
MOD_PIKK_1 | 128 | 134 | PF00454 | 0.762 |
MOD_PIKK_1 | 335 | 341 | PF00454 | 0.540 |
MOD_PK_1 | 331 | 337 | PF00069 | 0.433 |
MOD_PKA_2 | 159 | 165 | PF00069 | 0.552 |
MOD_PKA_2 | 273 | 279 | PF00069 | 0.786 |
MOD_PKA_2 | 283 | 289 | PF00069 | 0.594 |
MOD_PKA_2 | 321 | 327 | PF00069 | 0.464 |
MOD_Plk_1 | 190 | 196 | PF00069 | 0.481 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.507 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.428 |
MOD_Plk_4 | 312 | 318 | PF00069 | 0.613 |
MOD_Plk_4 | 331 | 337 | PF00069 | 0.423 |
MOD_Plk_4 | 346 | 352 | PF00069 | 0.360 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.476 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.559 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.504 |
MOD_SUMO_rev_2 | 101 | 106 | PF00179 | 0.573 |
MOD_SUMO_rev_2 | 191 | 200 | PF00179 | 0.578 |
MOD_SUMO_rev_2 | 341 | 347 | PF00179 | 0.600 |
TRG_DiLeu_BaEn_2 | 342 | 348 | PF01217 | 0.511 |
TRG_ENDOCYTIC_2 | 211 | 214 | PF00928 | 0.533 |
TRG_ENDOCYTIC_2 | 290 | 293 | PF00928 | 0.673 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.389 |
TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.518 |
TRG_Pf-PMV_PEXEL_1 | 104 | 108 | PF00026 | 0.400 |
TRG_Pf-PMV_PEXEL_1 | 178 | 183 | PF00026 | 0.553 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUB9 | Leptomonas seymouri | 68% | 100% |
A0A0S4J1V0 | Bodo saltans | 33% | 100% |
A0A1X0NWX4 | Trypanosomatidae | 45% | 100% |
A0A3S7WVU5 | Leishmania donovani | 98% | 100% |
A0A422NCM6 | Trypanosoma rangeli | 42% | 100% |
A4HYN1 | Leishmania infantum | 97% | 100% |
C9ZI59 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AI98 | Leishmania braziliensis | 87% | 100% |
E9AUI3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 99% |
V5BVI1 | Trypanosoma cruzi | 43% | 100% |